A prophylactic antibody-based immune therapy protects monkeys against severe disease caused by H5N1 avian flu, University of Pittsburgh and NIH Vaccine Research Center researchers report today in ...
Adding MF59 adjuvant to subvirion, egg-grown H5N1vaccine results in lowering the antigen dosage required to elicit a putative seroprotective response in approximately 60% of the subjects to 15 ...